Titan Pharmaceuticals Net Worth
Titan Pharmaceuticals Net Worth Breakdown | TTNP |
Titan Pharmaceuticals Net Worth Analysis
Titan Pharmaceuticals' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Titan Pharmaceuticals' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Titan Pharmaceuticals' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Titan Pharmaceuticals' net worth analysis. One common approach is to calculate Titan Pharmaceuticals' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Titan Pharmaceuticals' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Titan Pharmaceuticals' net worth. This approach calculates the present value of Titan Pharmaceuticals' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Titan Pharmaceuticals' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Titan Pharmaceuticals' net worth. This involves comparing Titan Pharmaceuticals' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Titan Pharmaceuticals' net worth relative to its peers.
Enterprise Value |
|
To determine if Titan Pharmaceuticals is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Titan Pharmaceuticals' net worth research are outlined below:
| Titan Pharmaceuticals is way too risky over 90 days horizon | |
| Titan Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Titan Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 184 K. Net Loss for the year was (5.57 M) with loss before overhead, payroll, taxes, and interest of (4.37 M). | |
| Titan Pharmaceuticals currently holds about 6.42 M in cash with (7.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44. | |
| Titan Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Roughly 45.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Titan Pharmaceuticals Overhauls Leadership, Settles with Ex-Directors - TipRanks.com - TipRanks |
Titan Pharmaceuticals uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Titan Pharmaceuticals. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Titan Pharmaceuticals' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Titan Pharmaceuticals Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Titan target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Titan Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Buy |
Most Titan analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Titan stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Titan Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationTitan Pharmaceuticals Target Price Projection
Titan Pharmaceuticals' current and average target prices are 7.09 and 7.00, respectively. The current price of Titan Pharmaceuticals is the price at which Titan Pharmaceuticals is currently trading. On the other hand, Titan Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Titan Pharmaceuticals Market Quote on 27th of April 2024
Target Price
Analyst Consensus On Titan Pharmaceuticals Target Price
Know Titan Pharmaceuticals' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Titan Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Titan Pharmaceuticals backward and forwards among themselves. Titan Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Titan Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Wells Fargo & Co | 2023-09-30 | 84.0 | Blackrock Inc | 2023-09-30 | 60.0 | Advisor Group Holdings, Inc. | 2023-09-30 | 50.0 | Global Wealth Strategies & Associates | 2023-12-31 | 40.0 | Morgan Stanley - Brokerage Accounts | 2023-09-30 | 16.0 | Westside Investment Management, Inc. | 2023-09-30 | 4.0 | Ubs Group Ag | 2023-09-30 | 4.0 | Qube Research & Technologies | 2023-09-30 | 4.0 | Mcclarren Financial Advisors, Inc. | 2023-09-30 | 3.0 | Bb&t Corp. | 2023-09-30 | 625.1 K | Renaissance Technologies Corp | 2023-09-30 | 135.7 K |
Follow Titan Pharmaceuticals' market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.41 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Titan Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Titan Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Project Titan Pharmaceuticals' profitablity
Titan Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Titan Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Titan Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Titan Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Titan Pharmaceuticals' profitability requires more research than a typical breakdown of Titan Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.69) | (0.72) | |
| Return On Capital Employed | (1.10) | (1.15) | |
| Return On Assets | (0.69) | (0.72) | |
| Return On Equity | (0.84) | (0.88) |
When accessing Titan Pharmaceuticals' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Titan Pharmaceuticals' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Titan Pharmaceuticals' profitability and make more informed investment decisions.
The data published in Titan Pharmaceuticals' official financial statements usually reflect Titan Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Titan Pharmaceuticals. For example, before you start analyzing numbers published by Titan accountants, it's critical to develop an understanding of what Titan Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Titan Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Titan Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Titan Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Titan Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Titan Pharmaceuticals' management manipulating its earnings.
Evaluate Titan Pharmaceuticals' management efficiency
Titan Pharmaceuticals has return on total asset (ROA) of (0.749) % which means that it has lost $0.749 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3914) %, meaning that it created substantial loss on money invested by shareholders. Titan Pharmaceuticals' management efficiency ratios could be used to measure how well Titan Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/27/2024, Return On Tangible Assets is likely to drop to -0.72. In addition to that, Return On Capital Employed is likely to drop to -1.15. As of 04/27/2024, Non Current Liabilities Other is likely to grow to about 1 M, while Total Current Liabilities is likely to drop slightly above 1.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 8.83 | 8.39 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 8.83 | 8.39 | |
| Enterprise Value Over EBITDA | 0.0006 | 0.0006 | |
| Price Book Value Ratio | 0.93 | 0.89 | |
| Enterprise Value Multiple | 0.0006 | 0.0006 | |
| Price Fair Value | 0.93 | 0.89 | |
| Enterprise Value | -731.9 K | -695.3 K |
The analysis of Titan Pharmaceuticals' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Titan Pharmaceuticals' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Titan Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue 443.338 | Revenue 184 K | Quarterly Revenue Growth (1.00) | Revenue Per Share 0.245 | Return On Equity (1.39) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Titan Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Titan Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Titan Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Titan Pharmaceuticals Corporate Filings
| 26th of April 2024 Other Reports | ViewVerify | |
F3 | 5th of April 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 3rd of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 27th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Titan Pharmaceuticals Earnings per Share Projection vs Actual
Be your own money manager
Our tools can tell you how much better you can do entering a position in Titan Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Titan Pharmaceuticals Corporate Directors
Titan Pharmaceuticals corporate directors refer to members of a Titan Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Titan Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Titan Pharmaceuticals' board members must vote for the resolution. The Titan Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Rajinder Kumar | Director | Profile | |
| James McNab | Director | Profile | |
| Federico Recli | Director | Profile | |
| David MacFarlane | Independent Director | Profile |
How to buy Titan Stock?
The net worth of Titan Pharmaceuticals is the difference between its total assets and liabilities. Titan Pharmaceuticals' net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Titan Pharmaceuticals' assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Titan Pharmaceuticals' net worth can be used as a measure of its financial health and stability which can help investors to decide if Titan Pharmaceuticals is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Titan Pharmaceuticals stock.Already Invested in Titan Pharmaceuticals?
The danger of trading Titan Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Titan Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Titan Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Titan Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Titan Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Titan Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Titan Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Titan Pharmaceuticals Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Titan Stock analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.41) | Revenue Per Share 0.245 | Quarterly Revenue Growth (1.00) | Return On Assets (0.75) | Return On Equity (1.39) |
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.